Geron carried out a Phase 1 clinical trial to assess the safety and preliminary activity of escalating doses of human embryonic stem cell (hESC) derived oligodendrocyte progenitor cells for treatment… ...

Research Objective We will identify SAR-CoV-2 T cell epitopes for vaccine development and specific TCRs for adoptive T cell therapy using a stem cell-based platform to generate specialized dendritic ...

Nos entristece profundamente saber del fallecimiento de un paciente que participaba en el ensayo clínico de fase 2 de Rocket Pharmaceuticals con RP-A501 para tratar la enfermedad de Danon. En nombre ...

SAN FRANCISCO, September 5, 2006 – The California Institute for Regenerative Medicine (CIRM) announced today that it has named Marcia Davey as Interim Financial Officer. The one-year appointment is ...

在基因工程领域，将大量遗传有效负载有效且稳定地插入包括人类诱导多能干细胞（iPSC）在内的原代人类细胞中仍然是一个艰巨的挑战。 传统方法，如逆转录病毒载体，由于半随机插入和基因沉默而面临局限性。 为了解决这些限制，我们的团队开发了一种新 ...

Clinical Trial Stage Projects Henry John Klassen A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa $5 ...

Trophoblast stem cells (TSCs) are crucial for developing the placenta, as they can produce all the cell types needed for its function. Culturing TSCs in the lab provides a valuable model to study how ...

We are deeply saddened to learn of the passing of a subject enrolled in Rocket Pharmaceuticals’ Phase 2 clinical trial of RP-A501 to treat Danon disease. On behalf of the California Institute for ...

Las células madre embrionarias pueden autorrenovarse en cultivo indefinidamente conservando la capacidad de diferenciarse en cualquier tipo de célula del cuerpo. Sin embargo, todavía no se comprende ...

Le Cadre d’allocation stratégique (CAS) reflète une vision affinée visant à garantir que les investissements du CIRM sont alignés sur sa mission. En savoir plus En 2024, le CIRM adopté un ensemble de ...

Strateginen allokointikehys (SAF) heijastaa hienostunutta visiota, jolla varmistetaan, että CIRMin sijoitukset ovat linjassa sen mission kanssa. Lisätietoja Vuonna 2024 CIRM hyväksyi joukon keskeisiä ...

在这里，我们证明人类神经干细胞（NSC）在实验性自身免疫性脑脊髓炎（EAE）（多发性硬化症（MS）小鼠模型）中促进髓鞘再生。这些研究表明，调节性 T 细胞 (Treg) 在人类 NSC 椎管内移植后被诱导，并且这些 Tregs 对于促进 EAE 的髓鞘再生和恢复至关重要。